kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the AMLX dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for AMLX.

AMLX

Amylyx Pharmaceuticals, Inc.
Pharmaceuticals · Pharmaceuticals
$102.57 sample
+0.47 (+0.46%) 1D
☆ Watch
Market cap
$281.5B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-09
Alerts
8
Price$102.57 +0.78% 3M daily closessample
105.8292.17
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: Director
  • Oct 19INSInsider sell: Chief Financial Officer
  • Oct 09SEC8-K filed: material event
  • Oct 02INSInsider sell: Director
  • Sep 29SEC8-K filed: material event
  • Sep 24INSInsider sell: EVP, Operations
  • Sep 16INSInsider sell: Director
  • Sep 08INSInsider sell: General Counsel
Sign up to see the real AMLX record →

Company facts

SEC EDGAR registration
Name
Amylyx Pharmaceuticals, Inc.
Sector
Pharmaceuticals
Industry
Pharmaceuticals
Smart-money score
+17sample, -100 to +100
Reporting currency
USD

Who is positioning in AMLX

sample
Insiders
23 insider transactions over 90 days, net selling, $863.6M
Congress
3 members traded over 90 days
Institutions · 13F
40 funds hold $3.8B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$10.3B +12.2% y/y
Q4 2024Q3 2026
Inventory$6.2B +14.4% y/y
Q4 2024Q3 2026
Accounts receivable$4.6B +13.6% y/y
Q4 2024Q3 2026
Total debt$12.0B +12.9% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$164.4B +12.0% 3M
Sample peer B
$222.7B +0.7% 3M
Sample peer C
$248.5B -12.9% 3M
Sample peer D
$178.4B -4.4% 3M
Sample peer E
$232.0B -3.9% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not AMLX's real figure. Nothing here is investment advice.